Main Session
Sep
28
PQA 04 - PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Nonmalignant Disease, Hematologic Malignancies, Palliative Care, and International/Global Oncology
2846 - RadVax for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy
Presenter(s)
Sidharth Ramesh, MD - Hospital of the University of Pennsylvania, Philadelphia, PA